# Annotation Confidence Framework

**A systematic approach to assigning and documenting cell type annotation confidence levels**

---

## Overview

Cell type annotation is **interpretation**, not fact. This framework helps you:
1. Systematically evaluate evidence for each annotation
2. Assign confidence levels based on multiple criteria
3. Document your reasoning
4. Communicate uncertainty appropriately

**Key Principle:** *It's better to report "likely CD4+ T cells" with honest uncertainty than to claim "CD4+ T cells" with false confidence.*

---

## Three-Tier Confidence System

### ðŸŸ¢ **HIGH CONFIDENCE (Level 1)**

**Definition:** Strong, multiple lines of evidence support this annotation with minimal ambiguity.

**Criteria (Must meet at least 4):**
- [ ] â‰¥3 canonical markers clearly expressed
- [ ] Marker expression highly specific to this cluster (log2FC > 1.5)
- [ ] Markers absent in other clusters
- [ ] Matches published marker sets from same tissue
- [ ] Automated tools (e.g., SingleR) agree
- [ ] Cluster biologically plausible for tissue context
- [ ] Known negative markers are absent

**Example:**
```
Cluster 5 â†’ "CD4+ T cells" [HIGH CONFIDENCE]

Evidence:
âœ“ CD3E+ CD4+ CD8- (canonical markers)
âœ“ IL7R+ LTB+ (additional T cell markers)
âœ“ CD8A/B negative (rules out CD8+ T cells)
âœ“ SingleR: T cells (score 0.89)
âœ“ Expected in PBMC sample
âœ“ log2FC (CD4) = 2.3 vs all other clusters
```

**Reporting:** Use definitive labels
- "CD4+ T cells"
- "Classical monocytes"
- "B cells"

---

### ðŸŸ¡ **MEDIUM CONFIDENCE (Level 2)**

**Definition:** Reasonable evidence but with some ambiguity, missing markers, or borderline specificity.

**Criteria (Meets 2-3 of Level 1 criteria, OR):**
- [ ] Some canonical markers present but not all
- [ ] Markers present but not highly specific (log2FC 0.5-1.5)
- [ ] Automated tools partially agree or show moderate scores
- [ ] Represents a subtype that's harder to distinguish
- [ ] Literature support limited or conflicting

**Example:**
```
Cluster 8 â†’ "Likely regulatory T cells (Tregs)" [MEDIUM CONFIDENCE]

Evidence:
âœ“ CD3E+ CD4+ (T cells confirmed)
âœ“ FOXP3+ (Treg marker, but low expression)
? IL2RA/CD25 low (expected to be high)
? No CTLA4 (another Treg marker)
âœ“ SingleR: T cells (score 0.72, subtype unclear)
âš  Could be activated CD4+ T cells instead
```

**Reporting:** Use qualified labels
- "Likely regulatory T cells"
- "CD4+ T cells (possibly Tregs)"
- "Monocyte subset (CD16+?)"
- "Probable plasmacytoid DCs"

---

### ðŸ”´ **LOW CONFIDENCE (Level 3)**

**Definition:** Weak evidence, high ambiguity, or novel population without clear markers.

**Criteria:**
- [ ] Few or no specific markers
- [ ] Markers conflict with expected biology
- [ ] Automated tools disagree or fail
- [ ] Could represent multiple cell types
- [ ] Potential doublets or low-quality cells
- [ ] Novel population not in literature

**Example:**
```
Cluster 12 â†’ "Unknown myeloid-like cells" [LOW CONFIDENCE]

Evidence:
? LYZ+ (general myeloid marker)
? Mixed expression of monocyte and DC markers
âœ— No clear canonical markers for any subtype
âœ— SingleR: Low scores across multiple types (<0.5)
âœ— High doublet score (0.35)
âš  May be doublets or stressed cells
âš  Consider sub-clustering or removing
```

**Reporting:** Use honest uncertainty
- "Unknown population"
- "Unidentified myeloid-like cells"
- "Cluster X (uncertain identity)"
- "Possible [cell type] (needs validation)"
- "Low-quality cells (consider filtering)"

---

## Evidence Scoring Matrix

Use this table to systematically score evidence for each annotation:

### Evidence Table Template

| Evidence Type | Score | Weight | Notes |
|--------------|-------|---------|-------|
| **Canonical markers (3+)** | 0-3 | Ã—2 | # markers clearly detected |
| **Marker specificity** | 0-3 | Ã—2 | log2FC relative to other clusters |
| **Negative markers** | 0-2 | Ã—1 | Expected absent markers are absent |
| **SingleR/automated** | 0-3 | Ã—1 | Score and consistency |
| **Literature support** | 0-2 | Ã—1 | Published marker sets match |
| **Biological plausibility** | 0-2 | Ã—1 | Makes sense in tissue context |
| **Sub-cluster coherence** | 0-2 | Ã—1 | Sub-clustering maintains identity |

**Total Score:** _____ / 30 possible

**Confidence Assignment:**
- **â‰¥20 points** â†’ HIGH CONFIDENCE (ðŸŸ¢)
- **12-19 points** â†’ MEDIUM CONFIDENCE (ðŸŸ¡)
- **<12 points** â†’ LOW CONFIDENCE (ðŸ”´)

---

## Detailed Evaluation Criteria

### 1. Canonical Markers (Most Important)

**What are canonical markers?**
- Well-established, widely cited markers for specific cell types
- Found in multiple publications and databases
- Protein-level validation exists (antibody staining, flow cytometry)

**How to score:**
- **3 points:** â‰¥3 canonical markers strongly expressed (mean expression > 1 in log-normalized)
- **2 points:** 2 canonical markers present
- **1 point:** 1 canonical marker present
- **0 points:** No canonical markers

**Examples:**

```
T cells:
- Essential: CD3E, CD3D
- Subtypes: CD4, CD8A, CD8B

B cells:
- Essential: CD79A, CD79B, MS4A1 (CD20)
- Plasma: MZB1, SDC1 (CD138)

Monocytes:
- Essential: LYZ, CD14, FCGR3A (CD16)
- Classical: CD14+ CD16-
- Non-classical: CD14low CD16+

NK cells:
- Essential: NKG7, GNLY, NCAM1 (CD56)
- Cytotoxic: GZMA, GZMB, PRF1
```

### 2. Marker Specificity

**How to assess:**

```python
# Calculate log2 fold change for marker in cluster vs all others
import scanpy as sc

# Find markers with minimum log2FC
sc.tl.rank_genes_groups(adata, 'cluster', method='wilcoxon', 
                         use_raw=False, 
                         pts=True)  # Include fraction detected

# Look at results
result = adata.uns['rank_genes_groups']
markers = sc.get.rank_genes_groups_df(adata, group='cluster_5')

# Check:
# - log2FC > 1.5 (strong specificity)
# - pct.1 > 50% (expressed in most cells of cluster)
# - pct.2 < 20% (rare in other clusters)
```

**Scoring:**
- **3 points:** log2FC > 2.0 for multiple markers, pct.1 > 70%, pct.2 < 10%
- **2 points:** log2FC > 1.5, pct.1 > 50%, pct.2 < 20%
- **1 point:** log2FC > 1.0, pct.1 > 30%, pct.2 < 30%
- **0 points:** log2FC < 1.0 or markers widely expressed

### 3. Negative Markers (Rules Out Other Types)

**Why important:** Confirming absence of markers for other cell types is as important as presence.

**Examples:**

```
Annotating CD4+ T cells?
Check that CD8A/CD8B are ABSENT (rules out CD8+ T cells)

Annotating CD8+ T cells?
Check that CD4 is ABSENT (rules out CD4+ T cells)

Annotating B cells?
Check that CD3E is ABSENT (rules out T cells)
Check that CD14 is ABSENT (rules out monocytes)

Annotating monocytes?
Check that CD3E is ABSENT (rules out T cells)
```

**Scoring:**
- **2 points:** All expected negative markers are clearly absent
- **1 point:** Most negative markers absent, some low expression
- **0 points:** Unexpected markers present (co-expression problem)

âš ï¸ **Warning:** If you see co-expression of lineage-incompatible markers (e.g., CD3E+ MS4A1+), suspect **doublets**!

### 4. Automated Annotation Agreement

**Tools to use:**
- **SingleR:** Reference-based annotation
- **CellTypist:** Marker-based annotation
- **Azimuth:** Reference mapping
- **scType:** Database-driven annotation

**How to interpret scores:**

```python
# SingleR example
import celltypist

# Load model and predict
model = celltypist.models.Model.load('Immune_All_Low.pkl')
predictions = celltypist.annotate(adata, model=model)

# Check scores
# High confidence: score > 0.8
# Medium: 0.5-0.8
# Low: < 0.5
```

**Scoring:**
- **3 points:** Multiple tools agree, scores > 0.8
- **2 points:** Tools partially agree, scores 0.6-0.8
- **1 point:** Tools agree weakly, scores 0.4-0.6
- **0 points:** Tools disagree or scores < 0.4

### 5. Literature Support

**Where to check:**
- **PanglaoDB:** https://panglaodb.se/ (cell type marker database)
- **CellMarker:** http://bio-bigdata.hrbmu.edu.cn/CellMarker/
- **PubMed:** Search "[cell type] markers [tissue]"
- **Original papers** describing similar datasets

**Scoring:**
- **2 points:** Multiple publications support exact marker combination
- **1 point:** General support but not exact match
- **0 points:** No literature support or contradicts literature

### 6. Biological Plausibility

**Ask yourself:**
- Is this cell type expected in this tissue?
- At this frequency?
- With these other cell types present?
- In this biological context?

**Examples:**

```
âœ… Plausible:
- T cells in blood (common)
- Neurons in brain (expected)
- Hepatocytes in liver (abundant)

âš ï¸ Questionable:
- Neurons in blood (very rare, contamination?)
- Plasma cells at 30% in healthy PBMC (too high)
- Cardiomyocytes in lung (wrong tissue)

âŒ Implausible:
- Photoreceptors in liver
- Red blood cells after filtering (should be removed)
- Cell types from different species (unless intentional)
```

**Scoring:**
- **2 points:** Highly plausible, expected in tissue
- **1 point:** Plausible but unexpected frequency
- **0 points:** Biologically implausible (investigate!)

---

## Annotation Workflow

### Step 1: Generate Marker Lists

```python
# Find top markers for each cluster
sc.tl.rank_genes_groups(adata, 'leiden', method='wilcoxon')

# Visualize top markers
sc.pl.rank_genes_groups(adata, n_genes=20)

# Get marker dataframe for specific cluster
markers = sc.get.rank_genes_groups_df(adata, group='0')
print(markers.head(20))
```

### Step 2: Check Canonical Markers

```python
# Create list of canonical markers to check
canonical_markers = {
    'T_cells': ['CD3E', 'CD3D', 'CD3G'],
    'B_cells': ['CD79A', 'CD79B', 'MS4A1'],
    'Monocytes': ['CD14', 'FCGR3A', 'LYZ'],
    'NK_cells': ['NKG7', 'GNLY', 'NCAM1'],
    'DCs': ['FCER1A', 'CST3', 'CLEC10A']
}

# Visualize on UMAP
for cell_type, markers in canonical_markers.items():
    sc.pl.umap(adata, color=markers, ncols=3, 
               title=[f"{m} ({cell_type})" for m in markers])
```

### Step 3: Run Automated Annotation

```python
# SingleR (R) or CellTypist (Python)
import celltypist

# Download model
celltypist.models.download_models()

# Predict
model = celltypist.models.Model.load('Immune_All_Low.pkl')
predictions = celltypist.annotate(adata, model=model)

# Add to adata
adata.obs['celltypist'] = predictions.predicted_labels

# Visualize
sc.pl.umap(adata, color=['leiden', 'celltypist'])
```

### Step 4: Manual Curation

For each cluster:

```python
# Create annotation template
cluster_id = 0

annotation_template = f"""
Cluster {cluster_id} Annotation
==============================

Top Markers:
{markers.head(10).to_string()}

Canonical Marker Check:
- CD3E: {check}
- CD79A: {check}
- [add more]

Automated Annotation:
- SingleR: {result}
- CellTypist: {result}

Proposed Label: _____________
Confidence: HIGH / MEDIUM / LOW
Reasoning: _____________
"""
```

### Step 5: Fill Evidence Matrix

| Cluster | Proposed Label | Evidence Score | Confidence | Notes |
|---------|----------------|----------------|------------|-------|
| 0 | CD4+ T cells | 24 | ðŸŸ¢ HIGH | Clear CD3+CD4+CD8- |
| 1 | B cells | 22 | ðŸŸ¢ HIGH | CD79A+ MS4A1+ CD3- |
| 2 | Classical monocytes | 20 | ðŸŸ¢ HIGH | CD14+ CD16- LYZ+ |
| 3 | NK cells | 18 | ðŸŸ¡ MEDIUM | NKG7+ but low GNLY |
| 4 | Likely CD8+ T cells | 15 | ðŸŸ¡ MEDIUM | CD8A+ but low expression |
| 5 | Unknown myeloid | 8 | ðŸ”´ LOW | Mixed markers, possible doublets |

---

## Special Cases

### Case 1: Doublet Clusters

**Symptoms:**
- Co-expression of lineage-incompatible markers (CD3E+ MS4A1+)
- Very high UMI/gene counts
- High doublet scores from Scrublet/DoubletFinder

**Action:**
```
Label: "Potential doublets (T/B cell)"
Confidence: N/A
Decision: REMOVE or mark for exclusion from downstream analysis
```

### Case 2: Low-Quality Clusters

**Symptoms:**
- Dominated by mitochondrial genes
- Very low marker specificity
- High ribosomal gene percentage
- Enriched for stress response genes

**Action:**
```
Label: "Low-quality cells"
Confidence: N/A
Decision: REMOVE or re-evaluate QC thresholds
```

### Case 3: Novel/Rare Populations

**Symptoms:**
- No clear canonical markers
- Not in reference databases
- Biologically plausible but undescribed

**Action:**
```
Label: "Unknown population (CD45+ LYZ+)"
Confidence: ðŸ”´ LOW
Notes: Potential novel subtype
Recommendation: Further validation needed
- Isolate and re-sequence
- Protein validation
- Functional assays
```

### Case 4: Transitional States

**Symptoms:**
- Express markers from multiple states
- Fall between canonical types on UMAP
- Markers suggest differentiation/activation

**Action:**
```
Label: "Activated T cells (transitioning)"
Confidence: ðŸŸ¡ MEDIUM
Notes: Intermediate activation state
- CD3E+ (T cell)
- CD69+ (activation)
- IL2RA+ (activation)
- Between naive and effector on UMAP
```

### Case 5: Cluster Should Be Split

**Symptoms:**
- Two sub-populations visible on UMAP
- Markers show heterogeneity within cluster
- Automated tools assign different labels

**Action:**
```
Recommendation: Sub-cluster!

# Subset cluster and re-cluster
cluster_3 = adata[adata.obs['leiden'] == '3']
sc.tl.leiden(cluster_3, resolution=0.5, key_added='sub_leiden')

# Annotate sub-clusters separately
```

### Case 6: Clusters Should Be Merged

**Symptoms:**
- No distinguishing markers between clusters
- Arbitrary split at current resolution
- Same cell type by all evidence

**Action:**
```
Clusters 2, 5, 8 â†’ Merge to "CD8+ T cells"
Confidence: ðŸŸ¢ HIGH (for merged identity)
Notes: Over-clustering artifact, no biological justification for split
```

---

## Documentation Template

### Annotation Report for [Dataset Name]

```markdown
# Cell Type Annotation Report

## Dataset Information
- Samples: ___
- Total cells (post-QC): ___
- Number of clusters: ___
- Tissue type: ___
- Sequencing platform: ___

## Annotation Summary

| Cluster ID | Cell Type | Confidence | % of Cells | Median Genes | Key Markers |
|------------|-----------|------------|------------|--------------|-------------|
| 0 | CD4+ T cells | ðŸŸ¢ HIGH | 32% | 1,234 | CD3E, CD4, IL7R |
| 1 | B cells | ðŸŸ¢ HIGH | 18% | 1,567 | CD79A, MS4A1, CD19 |
| ... | ... | ... | ... | ... | ... |

## High Confidence Annotations (Level 1)
[Detailed evidence for each]

## Medium Confidence Annotations (Level 2)
[Detailed evidence, alternative interpretations]

## Low Confidence Annotations (Level 3)
[Describe uncertainty, recommendations for follow-up]

## Decisions Made
- Clusters merged: [list]
- Clusters removed: [list] (reason: doublets/low-quality)
- Clusters requiring sub-clustering: [list]

## Validation Plan
- [ ] Check markers with protein data (if available)
- [ ] Compare to published datasets from same tissue
- [ ] Functional validation for [specific uncertain populations]

## Figures
1. UMAP colored by cluster + annotations
2. Dotplot of canonical markers
3. Heatmap of top markers per cluster
4. Confidence level distribution

## Caveats & Limitations
[List any concerns, ambiguities, or limitations]

## Conclusion
[Summary statement about annotation quality and readiness for downstream analysis]
```

---

## Best Practices

### DO:
âœ… Start with broad categories, refine iteratively
âœ… Check both positive AND negative markers
âœ… Use multiple automated tools and compare
âœ… Consult literature for your specific tissue
âœ… Document evidence for EVERY annotation
âœ… Report confidence levels honestly
âœ… Revisit annotations after downstream analysis
âœ… Get feedback from biologists familiar with the tissue

### DON'T:
âŒ Copy labels from automated tools without validation
âŒ Over-interpret low-confidence assignments
âŒ Ignore co-expression of incompatible markers
âŒ Claim high confidence without sufficient evidence
âŒ Force every cluster into a canonical category
âŒ Use annotation as final biological truth
âŒ Skip documentation ("I'll remember")

---

## Confidence Level Communication Guide

### In Publications:

**HIGH CONFIDENCE:**
> "We identified CD4+ T cells (cluster 0) based on expression of CD3E, CD4, and IL7R, and absence of CD8A/B."

**MEDIUM CONFIDENCE:**
> "Cluster 3 likely represents regulatory T cells based on CD4 and FOXP3 expression, though canonical Treg markers CTLA4 and IL2RA showed moderate expression."

**LOW CONFIDENCE:**
> "Cluster 7 expressed myeloid markers LYZ and CST3 but lacked clear subtype-specific markers. This population requires further characterization."

### In Figures:

```
Use consistent visual indicators:
ðŸŸ¢ = HIGH confidence (solid labels)
ðŸŸ¡ = MEDIUM confidence (labels with "likely" or "?")
ðŸ”´ = LOW confidence (labels with "unknown" or "uncertain")
```

### In Supplementary Materials:

Include full evidence table with:
- All markers checked
- Automated tool results
- Confidence scores
- Alternative interpretations

---

## Quick Reference Checklist

For each cluster annotation:

- [ ] **Top 20 markers identified** and reviewed
- [ ] **â‰¥3 canonical markers checked** (positive)
- [ ] **Negative markers checked** (rules out other types)
- [ ] **Automated annotation run** (SingleR/CellTypist)
- [ ] **Literature search performed** for tissue-specific markers
- [ ] **Biological plausibility assessed**
- [ ] **Evidence score calculated** (from matrix)
- [ ] **Confidence level assigned** (HIGH/MEDIUM/LOW)
- [ ] **Alternative interpretations considered**
- [ ] **Doublet potential evaluated**
- [ ] **Documentation completed**

---

## Summary

**Key Takeaways:**
1. **Annotation is interpretation**, not ground truth
2. **Confidence levels communicate uncertainty** appropriately
3. **Multiple lines of evidence** are essential
4. **Documentation** enables reproducibility and critique
5. **Honest uncertainty** is better than false confidence
6. **Validation** should guide future experiments

**Remember:** The goal is not perfect annotations, but **defensible annotations with clear evidence and appropriate confidence levels**.

---

**Next Steps:**
- Review `../labs/lab07_markers.ipynb` for marker identification
- See `../labs/lab08_manual_annotation.ipynb` for hands-on practice
- Check `../templates/annotation_report_template.md` for full report format
